ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

187 hedge funds and large institutions have $1.91B invested in Esperion Therapeutics in 2018 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 69 increasing their positions, 54 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
+22
Holders Change %
+13.33%
% of All Funds
4.29%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.16%
New
40
Increased
69
Reduced
54
Closed
17
Calls
$83.1M
Puts
$130M
Net Calls
-$46.6M
Net Calls Change
-$49.3M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$107M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$125M
3
PCM
3
Pentwater Capital Management
Florida
$167M
4
VOYA Investment Management
4
VOYA Investment Management
Georgia
$22.9M
5
Citadel Advisors
5
Citadel Advisors
Florida
$33.1M

Top Sellers

1
DCM
1
Discovery Capital Management
Connecticut
$14.4M
2
Millennium Management
2
Millennium Management
New York
$9.73M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$10.9M
4
GTC
4
Ghost Tree Capital
New York
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$13.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
TCM
26
Tekla Capital Management
Massachusetts
$13.7M +$13.7M +189,287 New
Goldman Sachs
27
Goldman Sachs
New York
$13.6M -$10.3M -143,078 -43%
MSE
28
MUFG Securities EMEA
United Kingdom
$13M – – –
PCM
29
Peregrine Capital Management
Minnesota
$13M -$5.54M -76,629 -30%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$12.9M +$337K +4,663 +3%
BG
31
Bellevue Group
Switzerland
$12.5M +$11.9M +164,920 +2,114%
AH
32
Aviva Holdings
Bahamas
$12.1M -$8.79M -121,513 -42%
Deutsche Bank
33
Deutsche Bank
Germany
$11.9M -$821K -11,347 -6%
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
$10.9M -$18.3M -252,723 -63%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$10.3M +$1.86M +25,695 +22%
Millennium Management
36
Millennium Management
New York
$9.73M -$18.3M -253,444 -65%
SAM
37
Sectoral Asset Management
Quebec, Canada
$9.58M +$7.89M +109,135 +468%
UBS Group
38
UBS Group
Switzerland
$8.02M +$1.95M +26,975 +32%
Norges Bank
39
Norges Bank
Norway
$7.66M +$7.66M +105,859 New
Invesco
40
Invesco
Georgia
$7.28M -$471K -6,517 -6%
IHM
41
Iguana Healthcare Management
New York
$7.23M -$4.7M -65,000 -39%
Charles Schwab
42
Charles Schwab
California
$6.9M +$323K +4,471 +5%
Lord, Abbett & Co
43
Lord, Abbett & Co
New Jersey
$6.65M -$10M -138,565 -60%
SG Americas Securities
44
SG Americas Securities
New York
$6.58M +$6.36M +87,950 +2,909%
BC
45
Broadfin Capital
New York
$6.28M +$6.28M +86,786 New
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$6.25M -$19.5K -270 -0.3%
Wellington Management Group
47
Wellington Management Group
Massachusetts
$5.49M +$3.47M +47,908 +171%
Morgan Stanley
48
Morgan Stanley
New York
$5.01M -$898K -12,416 -15%
NIP
49
Nicholas Investment Partners
California
$4.97M +$4.97M +68,748 New
UBS AM
50
UBS AM
Illinois
$4.83M +$107K +1,480 +2%
1
2
3 4 5